PT Darya-Varia Laboratoria Tbk (DVLA.JK)
IDR 1490.0
(2.76%)
IDR 1490.0
(2.76%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 130.66 IDR | -2.03% |
| 2022 | 133.37 IDR | 1.96% |
| 2021 | 130.81 IDR | -9.61% |
| 2020 | 144.71 IDR | -27.0% |
| 2019 | 198.24 IDR | 10.26% |
| 2018 | 179.80 IDR | 24.0% |
| 2017 | 145.00 IDR | 6.62% |
| 2016 | 136.00 IDR | 40.21% |
| 2015 | 97.00 IDR | 32.88% |
| 2014 | 73.00 IDR | -34.82% |
| 2013 | 112.00 IDR | -15.79% |
| 2012 | 133.00 IDR | 23.15% |
| 2011 | 108.00 IDR | 9.09% |
| 2010 | 99.00 IDR | 54.69% |
| 2009 | 64.00 IDR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 60.00 IDR | 44.47% |
| 2024 Q3 | 25.43 IDR | -45.95% |
| 2024 Q2 | 46.31 IDR | -22.82% |
| 2023 Q4 | 41.53 IDR | 1226.84% |
| 2023 FY | - IDR | -2.03% |
| 2023 Q1 | 54.39 IDR | 482.76% |
| 2023 Q2 | 31.61 IDR | -41.88% |
| 2023 Q3 | 3.13 IDR | -90.1% |
| 2022 Q4 | -14.21 IDR | -293.63% |
| 2022 Q1 | 122.34 IDR | 212.92% |
| 2022 Q2 | 28.86 IDR | -76.41% |
| 2022 FY | - IDR | 1.96% |
| 2022 Q3 | -3.61 IDR | -112.51% |
| 2021 Q4 | -108.34 IDR | -190.05% |
| 2021 FY | - IDR | -9.61% |
| 2021 Q1 | 72.00 IDR | 445.45% |
| 2021 Q2 | 46.78 IDR | -35.03% |
| 2021 Q3 | 120.31 IDR | 157.18% |
| 2020 Q1 | 50.00 IDR | 26.61% |
| 2020 Q4 | 13.20 IDR | 77.42% |
| 2020 Q3 | 7.44 IDR | -89.9% |
| 2020 FY | - IDR | -27.0% |
| 2020 Q2 | 73.68 IDR | 47.36% |
| 2019 Q3 | 56.99 IDR | 108.07% |
| 2019 Q1 | 75.00 IDR | 123.75% |
| 2019 Q2 | 27.39 IDR | -63.48% |
| 2019 FY | - IDR | 10.26% |
| 2019 Q4 | 39.49 IDR | -30.71% |
| 2018 FY | - IDR | 24.0% |
| 2018 Q4 | 33.52 IDR | -31.9% |
| 2018 Q3 | 49.22 IDR | 20.84% |
| 2018 Q2 | 40.73 IDR | -27.27% |
| 2018 Q1 | 56.00 IDR | 716.74% |
| 2017 Q2 | 33.60 IDR | -55.2% |
| 2017 Q3 | 45.97 IDR | 36.82% |
| 2017 Q1 | 75.00 IDR | 469.48% |
| 2017 FY | - IDR | 6.62% |
| 2017 Q4 | -9.08 IDR | -119.75% |
| 2016 Q2 | 24.04 IDR | -52.86% |
| 2016 Q4 | 13.17 IDR | -72.78% |
| 2016 FY | - IDR | 40.21% |
| 2016 Q1 | 51.00 IDR | 461.06% |
| 2016 Q3 | 48.38 IDR | 101.25% |
| 2015 Q3 | 18.32 IDR | 17.06% |
| 2015 FY | - IDR | 32.88% |
| 2015 Q1 | 54.00 IDR | 1856.52% |
| 2015 Q2 | 15.65 IDR | -71.02% |
| 2015 Q4 | 9.09 IDR | -50.38% |
| 2014 Q1 | -15.55 IDR | -156.73% |
| 2014 FY | - IDR | -34.82% |
| 2014 Q4 | 2.76 IDR | -88.84% |
| 2014 Q3 | 24.74 IDR | -59.05% |
| 2014 Q2 | 60.41 IDR | 488.49% |
| 2013 Q3 | 14.69 IDR | -52.8% |
| 2013 Q1 | 39.10 IDR | 9.19% |
| 2013 FY | - IDR | -15.79% |
| 2013 Q4 | 27.41 IDR | 86.59% |
| 2013 Q2 | 31.12 IDR | -20.41% |
| 2012 Q3 | 23.13 IDR | 0.0% |
| 2012 FY | - IDR | 23.15% |
| 2012 Q4 | 35.81 IDR | 54.82% |
| 2011 FY | - IDR | 9.09% |
| 2010 FY | - IDR | 54.69% |
| 2009 FY | - IDR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| PT Merck Tbk | 397.86 IDR | 67.159% |
| PT Phapros, Tbk | 7.09 IDR | -1742.877% |
| PT Pyridam Farma Tbk | -34.20 IDR | 482.047% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 31.69 IDR | -312.307% |
| PT Tempo Scan Pacific Tbk | 261.08 IDR | 49.954% |